Type 2 Diabetes Nutritional, Metabolic, Endocrine Type 2 Diabetes Mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Phase 1 1. Type 2 diabetes =1 year. 2. Aged between 25 and 75 3. Commencement of insulin or GLP-1 receptor agonist within the previous 12 months from the date of the audit 4. Refusal of insulin or GLP-1 receptor agonist within the previous 12 months from the date of the audit Phase 2 1. Type 2 diabetes diagnosed = 1 year 2. Aged between 25 and 75 3. HbA1c = 58 mmol/mol and =90 mmol/mol. 4. Transfer from oral hypoglycaemic treatment to injectable therapy judged appropriate by the consulting physician
Exclusion criteria
Exclusion criteria: Phase 2 1. Newly diagnosed type 2 diabetes 90 mmol/mol 4. Patients undergoing retinal photocoagulation therapy or dialysis treatment 5. Those currently in receipt of psychiatry or clinical psychology input 6. Within 3 months of undergoing a major event including MI, stroke and major surgery 7. Within 3 months of diagnosis or treatment of a major coexisting medical condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline between control and intervention group in the Problems Areas in Diabetes Scale (PAID). This will be measured at baseline (week 0 / first contact following consent to participate), week 12 and week 24. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change from baseline in the Hospital Anxiety and Depression Scale (HADS), the Pearlin Mastery scale, the Diabetes Empowerment Scale - short form (DES-SF), nutritional intake, HbA1c, lipid profile, body weight, BMI. This will be measured at baseline (week 0 / first contact following consent to participate), week 12 and week 24. | — |
Countries
United Kingdom